First patient treated with Leqembi® (lecanemab) in Sweden
Stockholm, Sweden, September 22, 2026 – BioArctic AB (publ) (Nasdaq Stockholm: BIOA B) announced today that Leqembi is now available at a private clinic in Sweden and that the first patient has started treatment. This is the first time a patient in Sweden has been treated outside of a clinical study since Leqembi recei…
Short extract only — this publisher licenses its text. Read the full release at the source.
More from Commercial newswire
- Bulletin from the Extraordinary General Meeting in Hansa Biopharma AB (publ)
- DexTech Medical AB: Annual Report 2025-07-01 - 2026-06-30
- #26-336 Delisting of Derivatives from NGM
The rest of this wire is for subscribers
Every release from this source, the moment it crosses — plus 80+ other newswires, saved searches and instant alerts.
7 days, no card required.
Read releases like this the second they cross the wire.
1,200+ — live on PPN World right now. Every release from this source, the moment it crosses — plus 80+ other newswires, saved searches and instant alerts.
Start the free trial →Your announcement next? Distribute your press release to the global wires with PPN Source — and track its pickup live here.
PPN Source →